Patients can speak more clearly. Swallowing improves. Facial symmetry is restored to a large extent. Most importantly, ...
The intake of oral semaglutides such as Wegovy or Rybelsus among adults with type 2 diabetes (T2D) was associated with a reduced risk of heart failure (HF) compared to those who took a placebo, ...
Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...
More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a buildup of fat in the liver. This condition can lead ...
BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced echocardiography data for the ...
A normal coronary angiogram does not always guarantee safety from a heart attack. Conditions like microvascular disease, ...
A new imaging technology called fast-RSOM lets researchers see the smallest blood vessels in the body without invasive procedures. It can detect early dysfunction in these vessels — a quiet warning ...
Heart disease is the number one cause of death for American women. This is partly because women often have lesser-known heart ...
More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a ...
NORTH LAS VEGAS ( FOX5) — Kira DeBarge Sullivan has spent years trying to reclaim her father’s former home from squatters.
"Clinical practice must move beyond the outdated notion that women are simply 'small men.'" ...
Data from the ORBITA-2 randomized, placebo-controlled trial emphasize that patient age alone should not be the deciding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results